D019 Validation of remote collection and quantification of blood neurofilament light in neurological diseases

<h3>Background</h3> Promising blood-based biomarkers of neuropathology have emerged with the potential for therapeutic development and disease monitoring. Remote sampling for biomarker assessment could ease the burden of in-person clinical visits and allow for frequent sampling. Here we evaluated a capillary finger-prick collection method for remote quantification of blood neurofilament light (NfL), a blood-based biomarker evident in various neurological disorders, and other exploratory markers of neuronal injury and neuroinflammation (GFAP, tau). <h3>Methods</h3> Matched samples from venepuncture and finger-prick were collected and processed into plasma and/or serum to directly compare NfL levels from a primary cohort of n=113 neurological patients (n=29 premanifest Huntington’s Disease (preHD), n=30 symptomatic Huntington’s Disease (HD), n=34 Multiple Sclerosis (MS), n=7 Amyotrophic Lateral Sclerosis (ALS), n=13 Parkinson’s Disease (PD)) and n=40 healthy controls. In the discovery cohort, two delayed processing conditions were compared, three- and seven-day delay, simulating ambient shipment. We recruited a confirmatory cohort of n=121 participants (n=64 preHD and n=57 healthy controls from the HD Young Adult Study) to validate the method. <h3>Results</h3> Capillary NfL and GFAP concentrations were equivalent to those in venous blood serum and plasma. Only NfL remained stable after seven-day processing delay. Capillary NfL replicated disease group differences displayed in venous blood. Findings were replicated in the confirmatory cohort. <h3>Conclusions</h3> This data supports our finger-prick method for remote collection and quantification of NfL. With the widespread applications for NfL across the spectrum of neurological disorders, this has the potential to transform disease monitoring, prognosis, and therapeutic development within clinical practice and research.

Authors

Institutions

Publication Details

Published
2024-09-01
DOI
https://doi.org/10.1136/jnnp-2024-ehdn.93
Primary Topic
Health, Environment, Cognitive Aging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

D019 Validation of remote collection and quantification of blood neurofilament light in neurological diseases

Ellen Camboe, Rachael I. Scahill, Jeremy Chataway, Edward J. Wild et al.
Health, Environment, Cognitive Aging
article

D019 Validation of remote collection and quantification of blood neurofilament light in neurological diseases

Ellen Camboe, Rachael I. Scahill, Jeremy Chataway, Edward J. Wild, Lauren M. Byrne, Kate Fayer, Marta Pengo, Mitsuko Nakajima, Sean Apap Mangion, Luca Zampedri, Michael J. Murphy, Sophie Field, Sarah J. Tabrizi, Yara Hassan, Alastair John Noyce, Vittoria Lombardi, Charles E. Wade, Brook Huxford, Mena S. Farag, Andrea Malaspina, Kamalesh C Dey, Amanda Heslegrave, Annabelle Coleman, Alexandra Zirra, Olivia Thackeray, Elizabeth L Broom, Natalie Donkor, Harriet Sorrell, Alexiane Touzé, Batoul Fneich, Aisha Ahmed, Ana Rita Gameiro Costa, Nicola Z. Hobbs, Henrik Zetterberg
article en

Abstract

<h3>Background</h3> Promising blood-based biomarkers of neuropathology have emerged with the potential for therapeutic development and disease monitoring. Remote sampling for biomarker assessment could ease the burden of in-person clinical visits and allow for frequent sampling. Here we evaluated a capillary finger-prick collection method for remote quantification of blood neurofilament light (NfL), a blood-based biomarker evident in various neurological disorders, and other exploratory markers of neuronal injury and neuroinflammation (GFAP, tau). <h3>Methods</h3> Matched samples from venepuncture and finger-prick were collected and processed into plasma and/or serum to directly compare NfL levels from a primary cohort of n=113 neurological patients (n=29 premanifest Huntington’s Disease (preHD), n=30 symptomatic Huntington’s Disease (HD), n=34 Multiple Sclerosis (MS), n=7 Amyotrophic Lateral Sclerosis (ALS), n=13 Parkinson’s Disease (PD)) and n=40 healthy controls. In the discovery cohort, two delayed processing conditions were compared, three- and seven-day delay, simulating ambient shipment. We recruited a confirmatory cohort of n=121 participants (n=64 preHD and n=57 healthy controls from the HD Young Adult Study) to validate the method. <h3>Results</h3> Capillary NfL and GFAP concentrations were equivalent to those in venous blood serum and plasma. Only NfL remained stable after seven-day processing delay. Capillary NfL replicated disease group differences displayed in venous blood. Findings were replicated in the confirmatory cohort. <h3>Conclusions</h3> This data supports our finger-prick method for remote collection and quantification of NfL. With the widespread applications for NfL across the spectrum of neurological disorders, this has the potential to transform disease monitoring, prognosis, and therapeutic development within clinical practice and research.

University College Hospital (GB), University of Wisconsin–Madison (US), Queen Mary University of London (GB), Barts Health NHS Trust (GB), Sahlgrenska University Hospital (SE), Royal London Hospital (GB), Huntington's Disease Association (GB), UK Dementia Research Institute (GB), NIHR Queen Square Dementia Biomedical Research Unit (GB), National Hospital for Neurology and Neurosurgery (GB), University College London (GB), University of Brescia (IT), University of Gothenburg (SE)
Openalex Percentile: Top 79%
Health, Environment, Cognitive Aging
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.